Genfit SA (GNFT)
5.76
-0.12
(-2.04%)
USD |
NASDAQ |
Nov 04, 16:00
5.76
0.00 (0.00%)
After-Hours: 20:00
Genfit Price to Book Value: 2.754 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 2.812 |
| October 31, 2024 | 2.798 |
| October 30, 2024 | 2.798 |
| October 29, 2024 | 2.635 |
| October 28, 2024 | 2.635 |
| October 25, 2024 | 2.630 |
| October 24, 2024 | 2.673 |
| October 23, 2024 | 2.726 |
| October 22, 2024 | 2.867 |
| October 21, 2024 | 2.843 |
| October 18, 2024 | 2.840 |
| October 17, 2024 | 3.027 |
| October 16, 2024 | 3.003 |
| October 15, 2024 | 2.826 |
| October 14, 2024 | 2.922 |
| October 11, 2024 | 2.898 |
| October 10, 2024 | 2.650 |
| October 09, 2024 | 2.654 |
| October 08, 2024 | 2.671 |
| October 07, 2024 | 2.611 |
| October 04, 2024 | 2.576 |
| October 03, 2024 | 2.534 |
| October 02, 2024 | 2.461 |
| October 01, 2024 | 2.421 |
| September 30, 2024 | 2.855 |
| Date | Value |
|---|---|
| September 27, 2024 | 2.726 |
| September 26, 2024 | 2.683 |
| September 25, 2024 | 2.573 |
| September 24, 2024 | 2.525 |
| September 23, 2024 | 2.386 |
| September 20, 2024 | 2.314 |
| September 19, 2024 | 2.004 |
| September 18, 2024 | 2.075 |
| September 17, 2024 | 2.023 |
| September 16, 2024 | 1.977 |
| September 13, 2024 | 1.961 |
| September 12, 2024 | 1.908 |
| September 11, 2024 | 1.994 |
| September 10, 2024 | 2.025 |
| September 09, 2024 | 1.961 |
| September 06, 2024 | 1.984 |
| September 05, 2024 | 2.004 |
| September 04, 2024 | 2.047 |
| September 03, 2024 | 1.961 |
| August 30, 2024 | 2.075 |
| August 29, 2024 | 2.099 |
| August 28, 2024 | 2.015 |
| August 27, 2024 | 1.898 |
| August 26, 2024 | 2.037 |
| August 23, 2024 | 2.080 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.142
Minimum
Jun 13 2022
9.074
Maximum
May 11 2020
3.240
Average
2.338
Median
Price to Book Value Benchmarks
| Edap TMS SA | 1.976 |
| DBV Technologies SA | 0.9524 |
| Cellectis SA | 1.192 |
| Ascendis Pharma AS | -- |
| Adaptimmune Therapeutics PLC | 2.190 |
Price to Book Value Related Metrics
| PE Ratio | 51.11 |
| PS Ratio | 4.170 |
| Price | 5.76 |
| Earnings Yield | 1.96% |
| Market Cap | 287.46M |
| Operating PE Ratio | 26.88 |
| Normalized PE Ratio | 54.73 |